Vanguard Group Inc Enanta Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,984,164 shares of ENTA stock, worth $14.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,984,164

Previous 1,981,866 0.12%

Holding current value

$14.9 Million

Previous $20.6 Million 44.49%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$5.75 - $12.99 $13,213 - $29,851	2,298 Added 0.12%	1,984,164 $11.4 Million
Q3 2024 Nov 13, 2024	BUY	$10.05 - $16.54 $477,133 - $785,253	47,476 Added 2.45%	1,981,866 $20.6 Million
Q2 2024 Aug 13, 2024	BUY	$11.43 - $17.02 $72,146 - $107,430	6,312 Added 0.33%	1,934,390 $25.1 Million
Q1 2024 May 10, 2024	BUY	$10.08 - $17.46 $1.35 Million - $2.34 Million	134,292 Added 7.49%	1,928,078 $33.7 Million
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $1.09 Million - $1.44 Million	133,266 Added 8.03%	1,793,786 $16.9 Million
Q3 2023 Nov 14, 2023	SELL	$11.09 - $22.13 $506,313 - $1.01 Million	-45,655 Reduced 2.68%	1,660,520 $18.5 Million
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $3.5 Million - $6.75 Million	169,272 Added 11.01%	1,706,175 $36.5 Million
Q1 2023 May 15, 2023	BUY	$38.82 - $54.59 $571,197 - $803,237	14,714 Added 0.97%	1,536,903 $62.2 Million
Q4 2022 Feb 10, 2023	BUY	$40.77 - $53.73 $1.85 Million - $2.43 Million	45,279 Added 3.07%	1,522,189 $70.8 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $1.92 Million - $2.84 Million	-39,779 Reduced 2.62%	1,476,910 $76.6 Million
Q2 2022 Aug 12, 2022	SELL	$38.13 - $76.93 $2.77 Million - $5.58 Million	-72,535 Reduced 4.56%	1,516,689 $71.7 Million
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $2.06 Million - $2.72 Million	-36,685 Reduced 2.26%	1,589,224 $113 Million
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $10.5 Million - $17 Million	-174,454 Reduced 9.69%	1,625,909 $122 Million
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $2.32 Million - $3.32 Million	-56,656 Reduced 3.05%	1,800,363 $102 Million
Q2 2021 Aug 13, 2021	BUY	$43.76 - $53.11 $81.3 Million - $98.6 Million	1,857,019 New	1,857,019 $81.7 Million

Others Institutions Holding ENTA

# of Institutions

107

Shares Held

19.7M

Call Options Held

9.7K

Put Options Held

12.4K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $155M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Enanta Pharmaceuticals Inc Transaction History